Company Overview
KIORA PHARMACEUTICALS INC
KPRXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
0M
2025 FY
Net Income
-11M
2025 FY
Shares Outstanding
4M
2025 FY
EPS
-2.6USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1372514
Exchange
Nasdaq
Location
US